Abstract

It has previously been shown that actinomycin D at a concentration of 0.08 μg/ml preferentially inhibits nucleolar (ribosomal) RNA synthesis in monolayer cultures of Chinese hamster cells. Treatment with 0.08 μg/ml actinomycin D of Chinese hamster cells, synchronized by mitotic selection, at the beginning of the G1 period causes a delay in the onset of DNA synthesis while a similar treatment in the late G1 period does not affect the process. The same effect has been produced by 9 μg/ml lucanthone (miracil D), a drug selectively inhibiting ribosomal RNA synthesis. The addition of 0.08 μg/ml actinomycin D to the stationary cultures stimulated to proliferate by medium changes completely prevents cells from entering the S period, when the drug is added to the medium in the first half of the pre-replicative period. However, in the second half of the pre-replicative period cells regain the ability to synthesize DNA in the presence of actinomycin D approximately to the same extent as do cells in the G1 period directly following mitosis. Thus, the demand for a de novo ribosomal RNA (rRNA) synthesis may be considered as a specific feature of cells induced to proliferate after a period of quiescence. The data obtained are consistent with the assumption that the first part of the pre-replicative period in stimulated quiescent cells is characteristic of G0 cells while later on the G0 cells enter the path of G1 cells typical for the rapidly proliferating cell populations.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.